Abstract: Sialyl Lewis x (sLe x ) derivatives conjugated to readily visualized molecular labels are useful chemical probes to study selectin ± carbohydrate interactions. Localization of the selectins on the surface of leukocytes and activated endothelial cells can be detected through fluorescence of bound selectin ligands. Herein we present a short chemoenzymatic synthesis of a fluorescently labeled bivalent sLe x conjugate. The use of an amino-substituted monovalent sLe x to obtain fluorescent-and biotin-labeled sLe x derivatives is also described. The cell-staining utility of the fluorescent sLe x conjugates is demonstrated for a HUVEC cell line expressing E-selectin and for CHO-K1 cells expressing either L-or E-selectin.
Introduction
Leukocyte adhesion to the vascular endothelium is a defining event in the inflammatory response. In the initial stages of this multistep process, leukocytes transiently tether and roll on the endothelial layer through adhesive interactions between the selectins and their carbohydrate ligands.
[1] The tetrasaccharides sialyl Lewis x (sLe x ), [2] sialyl Lewis a (sLe a ), [3] and sulfated derivatives thereof [4] have been identified as minimal carbohydrate epitopes recognized by selectins. Studies involving bi-, [5±8, 18] tri-, [7, 9, 10] tetra-, [11] and polyvalent [12±17] sLe x derivatives have suggested that the selectin ± ligand interaction may be multivalent in nature.
Bivalent sLe x derivative 1, previously reported by this laboratory, inhibits binding of HL-60 cells to immobilized E-selectin five times more efficiently than sLe x itself. [6a, b] Fluorescent derivatives of 1 therefore are of interest as cellstaining reagents [19] and as tools in the development of a fluorescence-based [20] E-selectin binding assay. [21] As such, N-glycoconjugate 2 was selected as a primary synthetic target in this study. The b-alanine spacer at the carbohydrate reducing terminus facilitated the incorporation of molecular probes at a position unlikely to interfere with the selectin ± ligand interaction. The strategy for the synthesis of 2 consisted of three stages: 1) chemical synthesis of trisacchar- ide-b-alanine conjugate 17, 2) tandem enzymatic introduction of six peripheral carbohydrates, and 3) attachment of the fluorescent label through amide coupling. Chemoenzymatic synthesis of monomeric sLe x derivative 22 has been previously reported by this laboratory. [18] Monomeric labeled sLe x derivatives were readily obtained through conjugation of 22 to molecular probes containing activated esters.
The utility of labeled sLe x -derivatives as cell-staining reagents was demonstrated for human umbilical vein endothelial cells (HUVEC) expressing E-selectin or chinese hamster ovary (CHO) cells expressing either L-or E-selectin. 
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The synthetic sLe x conjugates were shown to bind specifically to each selectin, in a manner similar to that of anti-selectin monoclonal antibodies (mAb).
Results and Discussion
Synthetic route to divalent 2: The structure GlcNAcb1,3(GlcNAcb1,6)GalbOR represents the branch point of the I blood group antigen and the core structure of bivalent sLe x derivative 2. The preparation of N-glycosides of this core structure has not been previously reported. The application of glycosyl azides in the synthesis of N-glycoconjugates is well established, [22] and this strategy was therefore chosen here. Specifically, Kunz et al. have utilized sLe
x glycosyl azides in the formation of multivalent sLe x conjugates. [9, 10] As follows, the main task in the synthesis of fluorescent conjugate 2 was to develop an efficient route to 3,6-diglycosylated galactosyl azides.
Synthesis of trisaccharide azide 12:
In order to circumvent extensive protecting group manipulations, the goal was to synthesize 12 following the concept of minimal protection and regioselective glycosylation. [23] The initial approach [24] was based on 3,4-O-isopropylidene derivative 5 as a substrate for preferred glycosylation at the primary 6-OH group. Thus, trisaccharide 12 was available in eight steps from penta-Oacetyl-b-d-galactopyranose (3) (Schemes 1 and 2). Treatment of known galactosyl azide 4 [25] with dimethoxypropane gave 3,4-O-isopropylidene derivative 5 in 86 % yield after cleavage [26] of the mixed acetal at the 6-hydroxyl. Small amounts of the 4,6-isomer (4 %) and the 2,3:4,6-di-O-isopropylidene compound (2 %) were also isolated from the reaction mixture. Diol acceptor 5 was then glycosylated with donor 6. [27] Unexpectedly, when dichloromethane was employed as the solvent, only 37 % of the desired (1,6)-linked disaccharide 7 was formed. The remainder of the reaction products were undesired regioisomer 8 (11 %) and trisaccharide 9 (32 %, yields based on azide 5). In nitromethane, however, the regioselectivity was acceptable, yielding 62 % of 7, 7 % of 8, and 9 % of 9.
[28] The position of the newly formed glycosidic bond in 7 was unambiguously deduced from the coupling pattern in the 1 H NMR spectrum of 7.
[29] Acetylation of 7 and removal of the isopropylidene group gave diol 11 (Scheme 2). In contrast to acceptor 5, glycosylation of the 2-O-acetylated acceptor 11 proceeded with remarkable regioselectivity at the equatorial 3-position and furnished 12 in 84 % yield. [30] In this reaction, dichloromethane was the solvent of choice, since the use of nitromethane under otherwise identical conditions resulted in incomplete reaction. However, in both cases, glycosylation at the 4-position of the 3,4-diol could not be detected. Since it is also possible to selectively glycosylate 4,6-diols in galactopyranosides at the 6-position, [6b, 23c,e,f] it was expected that the 2-O-acetylated 3,4,6-triol 14 would be a promising glycosyl acceptor for a simultaneous introduction of two glucosamine residues in the 3-and 6-positions of the galactose ring. [31] In an alternative synthetic strategy, 14 was efficiently obtained by making use of a 1,2-orthoester (Scheme 3). 
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Bromination [32] of pentaacetate 3, followed by cyclization [33] and deprotection gave orthoester 13 [34] as a mixture of epimers (endo/exo 83:17). The orthoester functionality served as a means to both distinguish the 2-OH group from the remaining hydroxyls and activate the anomeric carbon. Thus, treatment of triol 13 with trimethylsilyl azide [35] provided triol 14 in a single step in 90 % yield. In this case, acidic work-up was necessary to remove TMS ethers generated in situ. Silver triflate promoted diglycosylation of 14 with donor 6 in dichloromethane resulted in the formation of trisaccharide 12 in a yield of 70 %. Small amounts of intermediate 11 formed in the reaction were easily removed by flash chromatography. With this approach, trisaccharide 12 was accessible from pentaacetate 3 in only five steps and high overall yield.
Synthesis of trisaccharide-b-alanine conjugate 17: Deprotection of 12 with ethylene diamine, [36] followed by treatment with acetic anhydride, furnished peracetylated trisaccharide 15 in 90 % yield. Hydrazine hydrate could not be used to remove the phthaloyl groups as a result of a side reaction of the anomeric azido function. The azido function was smoothly reduced hydrogenolytically on palladium black, and the resulting glycosyl amine was coupled to Cbz-protected balanine with HBTU [37] as coupling reagent. O-Deacetylation utilizing Zemplen conditions gave glycoconjugate 17, which was used as a primer in subsequent glycosyltransferasecatalyzed [38] glycosylations.
Enzymatic glycosylations and attachment of the fluorophor:
Treatment of primer 17 with b-1,4-galactosyltransferase (b-1,4-GalT) and 2.6 equivalents of UDP-Gal gave pentasaccharide 18 in quantitative yield (Scheme 4). Similarly, two sialic acid residues were introduced with a-2,3-sialyltransferase (a-2,3-SiaT) to give heptasaccharide 19 (92 % yield). Subsequent addition of two fucose residues employing a-1,3-fucosyltransferase V (a-1,3-FucT V) then afforded nonasaccharide 20 (see above, 85 % yield). Alkaline phosphatase (AP) was added to all three glycosylation reactions in order to prevent product inhibition [39] by UDP, CMP, and GDP, respectively, and to facilitate product isolation from these nucleotides by size-exclusion chromatography. Notably, 17, 18, and 19 were accepted as substrates by the transferases despite the presence of the unnatural Cbz-b-alanine group at the reducing terminus. Finally, Cbz-protected glycoconjugate 20 was deprotected hydrogenolytically and reacted with BODIPY-succinimidyl ester 21, leading to fluorescently labeled nonasaccharide-b-alanine conjugate 2 in 89 % yield.
In summary, following the protecting group strategy presented in Schemes 3 and 4, the synthesis of 2 was accomplished in only 15 steps from commercially available 3.
Synthesis of fluorescent-and biotin-labeled derivatives 23 and 25: Recently, the synthesis of amino-substituted sLe x derivative 22 was described. Compound 22 was employed in the preparation of sLe x dimers with oligoethylene glycol based spacers of varying chain length. [18] As shown in Scheme 5, 22 was also coupled to the succinimidyl esters 21 and 24 to produce fluorescent BODIPY-labeled sLe x derivative 23 and biotinylated sLe x derivative 25 in 83 % and 65 % yields, respectively. Thus, labeled monovalent sLe x derivatives were also easily accessible by short chemoenzymatic routes.
Application of fluorescent sLe
x derivatives as cell-staining reagents: The cell-staining utility of the fluorescently labeled sLe x conjugates was then demonstrated. First, stable CHO-K1 cell lines expressing either L-selectin or E-selectin were generated. Full length L- [44] and E-selectin [45] were amplified with primers based on the published sequences by using the reverse transcriptase (RT) product as the template. These were subcloned in pcDNA.3, a mammalian expression vector with CMV promoter, and Neo gene as the selectable marker. In CHO-K1, the selectins were expressed on the cell surface with normal transmembrane topology. After transfection, cells incorporating the expression vector were selected by G418 resistance. For further selection, the individual colonies were grown in duplicate plates. One of the plates was used for ELISA, employing monoclonal antibodies for either L-selectin (mAb CD62L) or E-selectin (mAb CD62E), respectively. In the ELISA assay, individual CHO-K1 cell lines expressing L-or E-selectin were identified. The cell lines with maximal OD 450 were used for fluorescence activated cell sorting (FACS) analysis, and the top 0.1 % of cells showing expression were collected (Figure 1 ). These cells were grown in MEM (minimum essential medium) medium containing 5 % fetal calf serum, G418 (100 mg mL À1 ), and 1 % l-glutamine, and finally selected by limited dilution method.
In another set of experiments, HUVEC cells were stimulated to produce cell-surface E-selectin by treatment with lipopolysaccharide (LPS) and/or interferon-1b (IFN-1b) following previously published procedures. [2d, 12] Expression of E-selectin on the cell surface was verified by staining the activated cells with mAb CD62E, as described above. After the cells were washed, they were fixed and visualized under a fluorescence microscope. The antibody was detected at 570 nm by using TRITC-conjugated anti-mouse IgG.
After the expression of the cell-surface E-selectin was established, the cells were incubated with the BODIPYlabeled mono-and divalent sLe x conjugates. The cells were washed again, fixed, and visualized under a fluorescence microscope. BODIPY-labeled conjugates were detected by intrinsic fluorescence at 508 nm. Figure 2 shows the cell-staining experiments performed with the CHO-K1 cells expressing E-selectin, while Figure 3 shows similar experiments conducted with L-selectin. The Figure 2 . CHO-K1 cells expressing E-selectin: a) under transmitted light; b) stained with BODIPY-labeled sLe x monomer 23; c) cell stained with CD62E mAb followed by TRITC-conjugated anti-mouse IgG; d) under transmitted light; e) stained with BODIPY-labeled sLe x dimer 2; f) stained with CD62E mAb followed by TRITC-conjugated anti-mouse IgG. CHO-K1 cells negative for E-selectin expression did not exhibit staining with 2, 23, or CD62E mAb (data not shown).
staining of HUVEC cells expressing E-selectin is shown in Figure 4 . At the present levels of selectin expression, the cellstaining pattern observed is similar for the mAb and the sLe x derivatives for all cell lines investigated. Thus, the usefulness of the labeled sLe x derivatives in localizing E-and L-selectin on various cell surfaces has been established by these experiments. Though E-selectin expression has been visualized with fluorescent sLe x -based ligands previously, we are unaware of other reports of this nature involving the detection of L-selectin.
In the binding analysis of carbohydrate ligands for the selectins, it is necessary to verify that mimetic structures have access to the appropriate car- Figure 1 . FACS analysis of the TRITC-stained CHO-K1 stable cell lines: a) cells expressing E-selectin were stained with CD62E mAb followed by TRITC-conjugated anti-mouse IgG; b) cells expressing L-selectin were stained with CD62L mAb followed by TRITC-conjugated anti-mouse IgG. 0.1 % of the maximally intense cells were sorted out. x monomer 23; c) cell stained with CD62E mAb followed by TRITC-conjugated anti mouse IgG; d) another cell under transmitted light; e) cell stained with BODIPY-labeled sLe x dimer 2; f) cell stained with CD62E mAb followed by TRITC-conjugated anti mouse IgG. HUVEC cells negative for E-selectin expression did not exhibit staining with 2, 23, or CD62E mAb (data not shown).
bohydrate binding site. This is the advantage of using small molecular sLe x conjugates rather than anti-selectin mAbs in this type of experiment. Selectins with accessible carbohydrate recognition domains on the cell surface can be assessed directly utilizing the described sLe x constructs.
Conclusion
A short and efficient synthesis of fluorescently labeled bivalent sLe x -b-alanine conjugate 2 has been demonstrated with a combined chemical and enzymatic approach. The key features of the synthetic strategy were the transformation of unprotected orthoester 13 into selectively protected galactosyl azide 14, and subsequent regioselective diglycosylation to give trisaccharide 12. The b-alanine spacer introduced subsequently facilitated the incorporation of molecular probes, and also allows the possible formation of numerous neoglycoconjugates. [40] Glycosyltransferase-catalyzed elongation of the carbohydrate branches proceeded in excellent yields, despite the presence of the nonnatural Cbz-b-alanine group. Commencing with galactose pentaacetate 3, fluorescently labeled conjugate 2 was obtained in only 15 steps and an overall yield of 20 %. To demonstrate the utility of labeled sLe x -derivatives as tools in localizing cell-surface selectins, the sLe x conjugates were subjected to a cell-staining assay. Similar cell-staining patterns of the sLe x derivatives and anti-selectin mAbs on the surface of activated HUVEC cells and CHO-K1 cells was observed. As such, the usefulness of small molecular sLe
x -derivatives as cell-staining reagents has been established. Furthermore, these results may lead to the development of a fluorescence-based selectin binding assay in the near future.
Experimental Section
General methods: b-d-Galactopyranosyl azide (4), [25, 32, 42] 3,4,6-tri-Oacetyl-2-deoxy-2-phthalimido-b-d-glucopyranosyl bromide (6), [27] 1,2-O- (13), [32±34] and monoammonium GDP-Fuc [43] were prepared according to published procedures. 1,2,3,4,6-Penta-O-acetyl-b-d-galactopyranose (3), N-hydroxysuccinimidobiotin (24), UDP-Gal, b-1,4-GalT, and alkaline phosphatase (type VII-N, from bovine intestinal mucosa, P-2276) were purchased from Sigma (St. Louis, MO). CMP-NeuAc (sodium salt) was purchased from Calbiochem (San Diego, CA). 4,4-Difluoro-5,7-dimethyl-4-bora-[3a,4a]-diaza-s-indacene-3-propionic acid succinimidyl ester (21) (BODIPY FL, SE) was purchased from Molecular Probes (Eugene, OR). a-2,3-SiaT (3 U mL À1 ) and a-1,3-FucT V (2.16 U mL À1 ) were a kind donation from Cytel (San Diego, CA). Flash chromatography (FC) was performed on Mallinckrodt silica gel 60 (230 ± 400 mesh). Analytical thin-layer chromatography was performed by using silica gel 60 F 254 precoated glass plates from Merck (Darmstadt, Germany); compound spots were visualized by quenching of fluorescence and/or by charring after treatment with cerium molybdophoshate. Size-exclusion chromatography was performed on Bio-Gel P-2 Gel, fine and Bio-Gel P-4 Gel, fine (Bio-Rad Laboratories, Hercules, CA). NMR spectra were recorded on Bruker AM-250, AMX-400 or AMX-500 spectrometers. was dissolved in DMF (10 mL) and 2,2-dimethoxypropane (20 mL) and heated to 65 8C. p-Toluenesulfonic acid (90 mg, 0.473 mmol) was added and the solution was stirred at 65 8C for 5 h. After the solution was cooled down to rt, Et 3 N (660 mL, 4.73 mmol) was added and the mixture was stirred for 15 min. The mixture was concentrated to dryness and toluene was evaporated twice from the residue in order to remove traces of Et 3 N. The 
Procedure A: A solution of 5 (60 mg, 0.244 mmol) and 2,4,6-collidine (43 mL, 0.324 mmol) in nitromethane (3.5 mL) was mixed with powdered molecular sieves (4 ) (ca. 300 mg) and stirred under argon for 1.5 h at rt. Freshly dried AgOTf (76 mg, 0.295 mmol) was added and the yellowish mixture was cooled to À 20 8C. A solution of 6 (146 mg, 0.293 mmol) in nitromethane (3.5 mL) was added dropwise during 15 min to the reaction mixture. After 3 h at À 20 8C, the mixture was allowed to warm up slowly to rt. After a total reaction time of 8 h, the mixture was diluted with acetonitrile, filtered through Celite, and evaporated to give a syrup (324 mg). FC (25 g silica, toluene/ethyl acetate 1:1, then ethyl acetate) gave 9 (24 mg, 9 % based on 5), then 7 (100 mg, 62 %), 8 (11 mg, 7 %), and finally unreacted 5 (12 mg, 20 %).
Procedure B: Powdered molecular sieves (4 ) (ca. 150 mg) was added to a solution of 5 (60 mg, 0.244 mmol), 2,4,6-collidine (47 mL, 0.353 mmol), and freshly dried AgOTf (83 mg, 0.322 mmol) in dichloromethane (3 mL). The suspension was stirred under argon for 1 h at rt and then cooled to À 20 8C. A solution of 6 (146 mg, 0.293 mmol) was added dropwise during 15 min to the reaction mixture in dichloromethane (350 mL). After 1 h at À 20 8C, the mixture was allowed to warm up to rt and stirred for another 40 min. After dilution with dichloromethane, the mixture was filtered through Celite and evaporated. FC (25 g silica, toluene/ethyl acetate 1:1, then ethyl acetate) gave 9 (83 mg, 32 % based on 5), 7 (59 mg, 37 %), 8 (18 mg, 11 %), and unreacted 5 (12 mg, 20 %). Procedure B: A suspension of 14 (81 mg, 0.328 mmol), 2,4,6-collidine (164 mL, 1.25 mmol), and powdered molecular sieves (4 ) (ca. 600 mg) in dichloromethane (4.7 mL) was stirred under argon for 1 h at rt. After addition of freshly dried AgOTf (316 mg, 1.23 mmol), the mixture was cooled to À 30 8C and a solution of 6 (408 mg, 0.819 mmol) in dichloromethane (4.7 mL) was added dropwise during 5 min. The mixture was stirred for 1 h at À 30 8C, slowly warmed up to rt (2 h), and stirred for another 20 h at rt. After dilution with MeOH (5 mL) the suspension was filtered and evaporated. Purification by FC (100 g silica, hexane/ethyl acetate 1:4) gave 12 (247 mg, 70 %).
2-O-
Acetyl-6-O-(3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-d d-glucopyra- nosyl)-b-d d-galactopyranosyl
2-O-Acetyl-b-d d-galactopyranosyl azide (14):
A solution of 13 (1.14 g, 4.55 mmol) and TMS-N 3 (6 mL, 45.5 mmol) in THF (2 mL) was stirred at rt for 12 h and then refluxed (heating bath with 90 8C) for 22 h. After addition of 80 % aqueous HOAc (10 mL), the mixture was stirred at ca. (15): A solution of 12 (235 mg, 217 mmol) in n-butanol (30 mL) and ethylene diamine (6 mL) was stirred under Ar at 90 8C for 24 h. The solution was evaporated and the residue was coevaporated with toluene (2 Â 5 mL) and MeOH (2 Â 5 mL). The crude deprotected trisaccharide azide (R f 0.45, iPrOH/1m NH 4 OAc 2:1) was stirred with pyridine (10 mL) and acetic anhydride (5 mL) at rt for 18 h. The reaction mixture was evaporated and the residue was coevaporated with toluene (3 Â 10 mL) and MeOH (2 Â 5 mL) and purified by FC ( (17): A solution of 16 (71 mg, 63.0 mmol) in anhydrous MeOH (3 mL) was treated with a solution of NaOMe in anhydrous MeOH (0.1n, 1.2 mL) and stirred for 18 h at rt. The solution was neutralized with cation-exchange resin (AG 50W-X2, BioRad Laboratories, pyridinium form), filtered (water was used to rinse the resin), and evaporated to give 17 (43 mg, 86 %) as a white foam: R f 0. 51 (m, 1 H) (18) : Trisaccharide 17 (37.4 mg, 47.3 mmol), UDP-Gal (75 mg, 123 mmol), and MnCl 2´4 H 2 O (1m in H 2 O) (23.5 mL, 23.5 mmol) were dissolved in HEPES buffer (50 mm, pH 7.0) (4.7 mL) and b-1,4-galactosyltransferase (55 mL, 2.75 U) and alkaline phosphatase (7.5 mL, 37.6 U) were added. The mixture was gently shaken at 37 8C for 12 h. The precipitate formed was removed by centrifugation (23 700 g) and the supernatant purified by size-exclusion chromatography (Bio-Gel P-4, 2.5 Â 95 cm, 50 mm NH 4 HCO 3 ). Product containing fractions were pooled and lyophilized. To remove contaminant UDP-Gal, the crude product was dissolved in a small amount of H 2 O, applied to an anion-exchange column (Dowex-1 X8, HCO 3 À form) and eluted with H 2 O. Lyophilization gave 18 (66.5 mg, purity 79 %, corresponding to 53 mg pure 18, quant.) as a white fluffy powder contaminated with a small amount of HEPES buffer (21 %): R f 0.56 (iPrOH/1m NH 4 (19) : Pentasaccharide 18 (37.5 mg, 79 % purity, 26.7 mmol), CMP-NeuAc (55 mg, 76 mmol), MnCl 2´4 H 2 O (1m in H 2 O) (29 mL, 29 mmol), and Triton X-100 (11.6 mg in 387 mL H 2 O) were dissolved in HEPES buffer (100 mm, pH 7.0) (5.4 mL) and a-2,3-sialyltransferase (193 mL, 0.58 U) and alkaline phosphatase (3.5 mL, 17.4 U) were added. The mixture was gently shaken at 37 8C for 20 h and another portion of CMP-NeuAc (15 mg, 21 mmol) and a-2,3-sialyltransferase (100 mL, 0.3 U) were added. Incubation was continued for further 22 h and the mixture was filtered and evaporated. Size-exclusion chromatography (Bio-Gel P-4, 2.5 Â 95 cm, 100 mm NH 4 (20): Saccharide 19 (31 mg, 18.3 mmol), GDP-Fuc (34.5 mg, 55 mmol), and MnCl 2´4 H 2 O (1m in H 2 O) (110 mL, 110 mmol) were dissolved in MES buffer (50 mm, pH 6.0) (5.2 mL) and a-1,3-fucosyltransferase (254 mL, 0.55 U) and alkaline phosphatase (7.7 mL, 38.7 U) were added. The mixture was gently shaken at 37 8C for 48 h. The precipitate formed was removed by centrifugation (23 700 g) and the supernatant purified by size-exclusion chromatography (Bio-Gel P-4, 2.5 Â 95 cm, 100 mm NH 4 HCO 3 ). Lyophilization of product containing fractions gave 20 (31 mg, 85 %) as a white fluffy powder: R f 0.31 (iPrOH/ 1m NH 4 
A mixture of 20 (21.7 mg, 10.9 mmol), 10 % palladium on carbon catalyst (one spatula tip), MeOH (0.5 mL), and H 2 O (0.5 mL) was vigorously stirred under an hydrogen atmosphere (1 atm) at rt for 30 min. The mixture was filtered through Celite and evaporated. The crude nonasaccharide amine (19.3 mg, R f 0.07, iPrOH/1m NH 4 OAc 2:1) was dissolved in DMF (300 mL) and H 2 O (100 mL) and stirred with 21 (7.4 mg, 19 mmol) and Et 3 N (11 mL, 79.5 mmol) for 1 h at rt. Ten drops of a solution of NH 3 in MeOH (saturated at 0 8C) were added and stirring was continued for 15 min. The mixture was evaporated and purified by sizeexclusion chromatography (Bio-Gel P-2, 2.5 Â 70 cm, 100 mm NH 4 Biotin-conjugated sialyl Lewis x (25): NHS-biotin 24 (1.0 mg, 2.8 mmol) and dry triethylamine (70 mL, 5.1 mmol) were added to a solution of 22 (2.5 mg, 2.6 mmol) in dry DMF (330 mL). The reaction flask was covered in foil and the reaction allowed to stir at rt for 24 hours. Solvent was evaporated under reduced pressure, and the resulting residue was purified by size-exclusion chromatography (Bio-Gel P-2, 2.5 Â 65 cm, 50 mm NH 4 HCO 3 ). Lyophilization gave 25 as a white foam (2.0 mg, 65 % 35.0, 34.7, 27.5, 27.0, 26.9, 24.3, 24.2, 23.9, 21.5, 21.4, 21.2, 19.2, 14.4 RT-PCR and construction of the expression vector for hL-and hE-selectin: Human homologue of L-selectin (hL-selectin) was amplified with total RNA from human spleen tissue (Clontech, Palo Alto, CA) by RT-PCR. Total RNA was used for reverse transcription (RT) by using reverse transcriptase, following the suppliers protocol (Life Technologies, Gaithersburg, MD). This RT product was used for PCR. For amplification of L-selectin, the forward primer (5'-CGGAATTCATGATATTTCCATG-GAAATGTCAG-3'; with internal Eco RI site underlined) and the reverse primer (5'-GTTCTAGATTAATATGGGTCATTCATACTTCTC-3'; with internal Xba I site underlined) were used in 100 mL reaction mixture by using Pfu DNA polymerase (Stratagene, San Diego, CA) following the hotstart method. After 30 cycles, the reaction mixture was analyzed by agarose gel electrophoresis which showed the generation of a single major band of about 1.06 kb. The fragment was purified by agarose gel electrophoresis, followed by Geneclean. Subcloning in pcDNA.3 (Invitrogen, Carlsbad, CA) was done with Eco RI and Xba I digestion, followed by ligation. Transformation was carried out following usual procedure. The clone containing the plasmid DNA was grown in LB-ampicillin containing medium. Plasmid DNA was isolated and confirmed by double-stranded sequencing at TSRI core facility. Similarly, hE-selectin was amplified with the forward primer (5'-ATAA-GAATGCGGCCGCTAATGATTGCTTCACAGTTTCTCTC-3'; with internal Not I site underlined) and the reverse primer (5'-GCTCTA-GAAACTTAAAGGATGTAAGAAGGCTTTTG-3'; with internal Xba I site underlined). The full length cDNA was amplified by using Pfu DNA polymerase. The amplification yielded a major band of 1.825 kb. This was purified by agarose gel electrophoresis, followed by Geneclean. Subcloning in pcDNA.3 was carried out by using Not I and Xba I. The clone containing the plasmid DNA was grown in LB-ampicillin medium. The plasmid DNA was isolated and verified by double-stranded sequencing in the TSRI core facility.
Transfection of cDNAs in CHO-K1 and isolation of stable cell lines by ELISA: CHO-K1 cells were routinely grown in MEM medium containing 5 % fetal calf serum and 1 % glutamine. The plasmid DNAs for full length hL-selectin or hE-selectin were used to transfect freshly grown CHO-K1 cells with Lifofectamine, following the procedure of the supplier (Life Technologies). After 48 hrs of transfection, cells were digested with trypsin and replated on medium containing G418. After about two weeks, individual colonies were isolated by trypsin digestion, and were grown in 48 well plates containing G418 in the medium. The cells were incubated at 37 8C and used for selection in an ELISA assay as follows: the G418 resistant transfected cells (about 10 4 cells) expressing selectin were added into a polylysine-coated Falcon 96 well plate (a replica plate for each was also made and saved) and incubated overnight at 37 8C. The medium was removed and the cells were washed with PBS. The plates were blocked for one hour with blocking buffer (PBS1 % human serum [Sigma]) at room temperature. These were washed three times with PBS. Primary antibody (50 mL per well, Pharmingen, San Diego, CA) diluted in the blocking buffer (1:500) was added and incubated for 2 hrs at rt (or 4 8C overnight). The cells were washed three times with PBS, and then sheep anti-mouse IgG-HRP conjugated antibody (50 mL per well, Amersham) diluted in the blocking buffer (1:1000) was added. The cells were incubated one hour at rt and then washed three times with PBS. The color was developed by the addition of TMB peroxidase substrate (50 mL per well; Pierce, Rockford, IL). The reaction was quenched with 1m phosphoric acid (50 mL per well), and the plates were read at OD 450 . The wells containing cells with maximal OD 450 by ELISA were selected. The expression of selectins by these cells was also verified by sandwich ELISA. Plates were coated with anti-selectin antibody, incubated overnight at 4 8C, and then used for ELISA as above. Two clones for each (hL-selectin and hE-selectin) were selected. A control cell line incorporating the vector only was selected by G418 resistance. The cells with OD 450 over this control cell line were considered positive in the assay. Two clones for each of the selectin-expressing stable cell lines were selected for final sorting by a cell sorter.
FACS analysis and isolation of transfected clones:
The cell lines selected by ELISA were grown until confluency in MEM medium containing 5 % fetal calf serum. These (% 10 7 cells mL À1 ) were digested with trypsin, collected in a Falcon tube and washed three times with PBS for staining in solution by using anti-selectin (either hL-or hE-) antibody as follows: the cells were incubated for one hour in the blocking buffer (PBS containing 0.5 % human serum) at rt. The blocking buffer was removed by washing the cells in PBS. Anti-selectin antibody diluted in the blocking buffer (1:500) was added and the cells were incubated at rt for 45 min. These cells were washed four times with PBS at room temperature, and TRITC-conjugated anti-mouse IgG antibody was used as a secondary antibody (diluted 1:1000 in blocking buffer). Incubation was carried out for one hour (in the dark) at room temperature. The cells were washed again four times with PBS, finally suspended in 400 mL of PBS containing 0.1 % bovine serum albumine (BSA), and 25 mm HEPES for FACS analysis. 0.1 % of the maximally intense cells were sorted out (Vantage, TSRI core facility) and collected in 200 mL of fetal calf serum. These were then transferred to a T25-tissue culture flask containing MEM medium and placed in a CO 2 incubator at 37 8C for two weeks of growth. These cells were used for immunofluorescence microscopy.
Activation of HUVEC cells: HUVEC monolayers grown in endothelial cell growth medium (Cell Applications, Inc., San Diego, CA) were seeded at the second passage onto 35 mm glass coverslips treated with fibronectin (treated with 20 mg mL À1 for 1 ± 2 hrs). These were grown to confluency in complete M199 culture medium in a 5 % CO 2 incubator at 37 8C. The cells were activated for 4 h with LPS (100 ng mL À1 ) following the method of Welply et al. [12] These were washed three times with PBS (Dulbecco phosphate-buffered saline solution without calcium and magnesium salts; Irvine Scientific, CA) and fixed in 1 ± 2 % freshly prepared formaldehyde (made in PBS without calcium and magnesium salts) for 35 ± 50 min at room temperature. Before staining, the cells were washed twice with 0.1m glycine in PBS and then incubated in blocking buffer (0.5 % human serum in PBS) for 45 min. For experiments involving CHO-K1, cells (about 10 6 cells per plate) were plated in a 100 cm plate containing fibronectin treated cover slips. The cells were grown in MEM medium (containing 5 % fetal calf serum and 1 % lglutamine) until 80 ± 90 % confluency on the cover slips was observed under a light microscope. The cells were washed twice in PBS and then fixed in formaldehyde, as above.
Immunofluorescence microscopy: For detection of E-selectin expression, the cells were washed and then incubated for 1 h at room temperature in 50 mL of blocking buffer containing 1:100 dilution of affinity purified antihuman CD62E monoclonal antibody (Pharmingen, San Diego, CA). These were washed three times in PBS, and incubated for 45 min at room temperature in 1:100 dilution of tetramethylrhodamine isothiocyanate (TRITC)-conjugated anti-mouse IgG (Fab specific) in blocking buffer. For study of the fluorescent synthetic ligands, the cells were incubated for 45 min at room temperature in BODIPY-conjugated oligosaccharide (6.5 mm in PBS containing 1 mm each of calcium and magnesium salts). Cells were washed four times with PBS (containing calcium and magnesium) and mounted on microscope slides with approximately 20 mL of mounting medium (Molecular Probes, Inc., Eugene, OR). These were visualized by using a Nikon Microphot-FXA microscope. Pictures were taken with a digital CCD camera and were processed with Adobe Photoshop.
